References
- Chowdhury EH. Strategies for tumor-directed delivery of siRNA. Expert Opin Drug Deliv 2011; 8:389 - 401
- Katakowski JA, Palliser D. Optimizing siRNA delivery to the genital mucosa. Discov Med 2011; 11:124 - 132
- Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 2010; 11:59 - 67
- Krebs MD, Alsberg E. Localized, targeted and sustained siRNA delivery. Chem Eur J 2011; 17:3054 - 3062
- Han HD, Mora EM, Roh JW, Nishimura M, Lee SJ, Stone RL, et al. Chitosan hydrogel for localized gene silencing. Cancer Biol Ther 2011; 11:839 - 845
- Dash R, Azab B, Shen XN, Sokhi UK, Sarkar S, Su ZZ, et al. Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic. Discov Med 2011; 11:46 - 56
- Bhatia VK, Senior R. Contrast echocardiography: evidence for clinical use. J Am Soc Echocardiogr 2008; 21:409 - 416
- Katakowski M, Buller B, Wang X, Rogers T, Chopp M. Functional microRNA is transferred between glioma cells. Cancer Res 2010; 70:8259 - 8263
- Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, et al. Gap junction-mediated import of microrna from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 2011; 71:1550 - 1560